![Tony Kennedy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tony Kennedy
Chief Tech/Sci/R&D Officer at
F2G Ltd.
Profile
Tony Kennedy is currently the Chief Scientific & Development Officer at F2G Ltd. Prior to this, he worked as a Principal at Smithkline Beecham Plc, Head-Project Management at Roche Pharmaceuticals, Inc., and as a Member at Hoffmann-La Roche, Inc. He also served as Vice President-Development at Trigen Holdings AG from 2002 to 2009 and as Head-Development at Vantia Ltd. Dr. Kennedy holds a graduate and doctorate degree from the University of London and an undergraduate degree from the University of Surrey.
Tony Kennedy active positions
| Companies | Position | Start |
|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Chief Tech/Sci/R&D Officer | 11/01/2010 |
Former positions of Tony Kennedy
| Companies | Position | End |
|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Corporate Officer/Principal | 15/12/2009 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides molecule agonists of vasopressin receptors | Corporate Officer/Principal | - |
Training of Tony Kennedy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Provides molecule agonists of vasopressin receptors | Commercial Services |
- Stock Market
- Insiders
- Tony Kennedy
